Soft tissue sarcoma is a form of cancer that occurs due to abnormal and uncontrolled cell growth of the soft tissues of the body.

These tissues connect, support and surround other body parts and may include muscle, fat, blood vessels, lymph vessels, nerves, tendons and the lining of joints.

Many people with early soft tissue sarcoma have no signs or symptoms of the condition.

When present, symptoms depend on the location and size of the tumor but may include a palpable lump under the skin, pain, or difficulty breathing.

Most cases occur sporadically in people with little to no family history of the condition.

The best treatment options depend on many factors but may include surgery, chemotherapy, and radiation therapy.

Soft Tissue Sarcoma, also known as non-rhabdomyosarcoma soft tissue sarcoma, is related to malignant fibrous histiocytoma and sarcoma, synovial.

An important gene associated with Soft Tissue Sarcoma is TP53 (Tumor Protein P53), and among its related pathwayssuperpathways are Innate Immune System and ERK Signaling.

The drugs Efavirenz and Bleomycin have been mentioned in the context of this disorder.

Affiliated tissues include bone, uterus and t cells, and related phenotypes are cardiovascular system and immune system MedlinePlus.

Your soft tissues connect, support, or surround other tissues.

Sometimes they spread and can press on nerves and organs, causing problems such as pain or trouble breathing.

They are not common, but you have a higher risk if you have been exposed to certain chemicals, have had radiation therapy, or have certain genetic diseases.

Treatments include surgery to remove the tumor, radiation therapy, chemotherapy, or a combination.

A soft-tissue sarcoma (STS) is a malignant tumour, a type of cancer, that develops in soft tissue.

Sarcoma Study Group of the Connective Tissue Oncology Society.

Doxorubicin Plus Placebo in Patients With Front-line Metastatic Soft Tissue Sarcoma.

Doxorubicin Alone in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma.

Standard Dose Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma.

Simon Curtis Alter Boy Rar